{"id":"repevax-concomitant","safety":{"commonSideEffects":[{"rate":"30-50","effect":"Injection site reactions (pain, redness, swelling)"},{"rate":"10-20","effect":"Myalgia"},{"rate":"10-20","effect":"Headache"},{"rate":"5-15","effect":"Fatigue"},{"rate":"1-5","effect":"Fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"REPEVAX contains inactivated toxoids and antigens from Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, and poliovirus types 1, 2, and 3. When administered as a booster dose, it reactivates and reinforces the adaptive immune response (both humoral and cellular) against these pathogens, maintaining protective antibody levels and cellular immunity in previously vaccinated individuals.","oneSentence":"REPEVAX is a booster vaccine that provides protection against diphtheria, tetanus, pertussis, and poliomyelitis by stimulating immune memory responses.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:31:53.210Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Booster vaccination against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults"}]},"trialDetails":[{"nctId":"NCT02526394","phase":"PHASE4","title":"Pertussis and Meningitis C Concomitant Vaccination in Adolescents","status":"COMPLETED","sponsor":"Public Health England","startDate":"2013-09","conditions":"Pertussis, Meningitis, Preventive Immunization; Meningitis","enrollment":400},{"nctId":"NCT01073293","phase":"PHASE3","title":"A Study of V503 Vaccine Given Concomitantly With REPEVAX™ in 11 to 15 Year Olds (V503-007)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-04-22","conditions":"Papillomavirus Infections","enrollment":1054},{"nctId":"NCT00337428","phase":"PHASE3","title":"Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-05","conditions":"Neoplasms, Glandular and Epithelial, Diphtheria, Tetanus","enrollment":843}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"REPEVAX™ (Concomitant)","genericName":"REPEVAX™ (Concomitant)","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Biologic","firstApprovalDate":"","aiSummary":"REPEVAX is a booster vaccine that provides protection against diphtheria, tetanus, pertussis, and poliomyelitis by stimulating immune memory responses. Used for Booster vaccination against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}